Home > Insider Trading > Filing (0001209191-14-061642)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1550395	David Altshuler	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Transaction Summary

Sold:	10,595 shares	Avg. Price: $107.74	Total Value: $1,141,531.20

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-10-01	10,595	$63.14	10,595	No	4	M	Direct
Common Stock	Disposition	2014-10-01	2,381	$106.56	8,214	No	4	S	Direct
Common Stock	Disposition	2014-10-01	4,942	$107.56	3,272	No	4	S	Direct
Common Stock	Disposition	2014-10-01	2,177	$108.31	1,095	No	4	S	Direct
Common Stock	Disposition	2014-10-01	695	$109.51	400	No	4	S	Direct
Common Stock	Disposition	2014-10-01	300	$110.48	100	No	4	S	Direct
Common Stock	Disposition	2014-10-01	100	$112.06	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-10-01	10,595	$0.00	10,595	$63.14

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
19,405		2022-05-23	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $106.56 (range $106.00 to $106.96).
Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $107.56 (range $107.00 to $107.98).
Open market sales reported on this line occurred at a weighted average price of $108.31 (range $108.00 to $108.76).
Open market sales reported on this line occurred at a weighted average price of $109.51 (range $109.17 to $110.09).
Open market sales reported on this line occurred at a weighted average price of $110.48 (range $110.39 to $110.66).
The option vests in 16 quarterly installments from 05/24/2012.